Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP

Rank in Stocks #11772
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Share Price
$6.89
Last synced: 2026-11-18
Market Cap
$503.43M
Change (1 day)
-4.31%
Change (1 year)
-
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
P/B ratio for Cybin Inc. Common Stock (HELP)
P/B ratio as of November 2026 TTM: 2.30
According to Cybin Inc. Common Stock's latest financial reports and stock price, its current price-to-book ratio (TTM) is 2.30. At the end of 2025 the company had a P/B ratio of 7.14.
P/B ratio history for Cybin Inc. Common Stock from 2017 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 2.30 -67.81%
2025 7.14 1,050.06%
2024 0.62 -99.21%
2023 78.89 4.77%
2022 75.29 -97.88%
2021 3.54K 254.65%
2020 999.07 -20.49%
2019 1.26K -67.26%
2018 3.84K 126.59%
2017 1.69K 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.5305 184.14%
US
13.101 470.03%
US
4.451 93.66%
AU
4.8339 110.33%
BE
7.2161 213.98%
NL

Questions about Cybin Inc. Common Stock's P/B ratio

What is Cybin Inc. Common Stock's P/B ratio?

Cybin Inc. Common Stock's P/B ratio is 2.30, as of Nov 2026.

What was Cybin Inc. Common Stock's P/B ratio in 2025?

In 2025, Cybin Inc. Common Stock's P/B ratio was 7.14, compared with 0.62 in 2024.

How has Cybin Inc. Common Stock's P/B ratio changed since 2020?

From 2020 to 2025, Cybin Inc. Common Stock's P/B ratio was highest in 2021 (3.54K) and lowest in 2024 (0.62).

How does Cybin Inc. Common Stock's P/B ratio compare with similar companies?

Cybin Inc. Common Stock's P/B ratio (2.30) is lower than that of all 5 similar companies listed above. The highest among them is Moderna, Inc., with 13.10.